High materiality7/10
Kymera Therapeutics (KYMR) PT Raised to $125 at Oppenheimer
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Oppenheimer raises KYMR target to $125; current price around $105.48.
- Oppenheimer raises KYMR target to $125; price $105.48.
Key facts
- 01
Target: $125
- 02
Posted price: $105.48
- 03
Analyst firm: Oppenheimer
- 04
Analyst: Jeff Jones
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.